Neuropeptide Y attenuates naloxone-precipitated morphine withdrawal via Y5-like receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 2, 1998, Pages 633-636

  Woldbye, David P D ^a   Klemp, Kristian ^a   Madsen, Torsten M ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

H 3326; MORPHINE; N 5017; N 6146; N 6521; NALOXONE; NEUROPEPTIDE Y; NEUROPEPTIDE Y DERIVATIVE; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y [13-36]; NEUROPEPTIDE Y [31 LEUCINE 34 PROLINE]; P 5801; PANCREAS POLYPEPTIDE; PEPTIDE YY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; DRUG WITHDRAWAL; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; JUMPING; MALE; MOTOR ACTIVITY; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; RAT; WET DOG SHAKES; WITHDRAWAL SYNDROME;

EID: 0031886448     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Bläsig J, Herz A, Reinhold K and Zieglgänsberger S (1973) Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacologia 33:19-38.
2. Bläsig J, Papeschi R, Gramsch C and Herz A (1976) Central serotonergic mechanisms and development of morphine dependence. Drug Alcohol Depend 1:221-229.
3. Blomqvist AG and Herzog H (1997) Y-receptor subtypes - how many more? TINS 20:294-298.
4. Broqua P, Wettstein JG, Rocher MN, Gauthier-Martin B, Riviere PJ, Junien JL and Dahl SG (1996) Antinociceptive effects of neuropeptide Y and related peptides in mice. Brain Res 724:25-32.
5. Calvino B, Lagowska J and Ben-Ari Y (1979) Morphine withdrawal syndrome: Differential participation of structures located within the amygdaloid complex and striatum of the rat. Brain Res 177:19-34.
6. Chronwall BM, DiMaggio DA, Massari VJ, Pickel VM, Ruggiero DA and O'Donohue TL (1985) The anatomy of neuropeptide Y-containing neurons in the rat brain. Neuroscience 15:1159-1181.
7. De Quidt ME and Emson PC (1986) Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system. II. Immunohistochemical analysis. Neuroscience 18:545-618.
8. Dumont Y, Martel JC, Fournier A, St-Pierre S and Quirion R (1992) Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog Neurobiol 38: 125-167.
9. Gerald C, Walker MW, Criscione L, Gustafson EL, Batzl-Hartmann C, Smith KE, Vaysse P, Durkin MM, Laz TM, Linemeyer DL, Schaffhauser AO, Whitebread S, Hofbauer KG, Taber RI, Branchek TA and Weinshank RL (1996) A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 382:168-171.
10. Gescuk B, Lang S, Porrino LJ and Kornetsky C (1994) The cerebral metabolic effects of morphine in rats exposed to escapable footshock. Brain Res 663:303-311.
11. Gustafson EL, Gerald C, Durkin MM, Smith KE, Walker MW, Moralishvilli A, Vaysse PJ-J, Weinshank RW and Branchek TA (1996) Localization of the mRNA encoding a novel NPY receptor subtype in rat brain. Soc Neurosci Abstr 22:1682.
12. Heilig M, McLeod S, Brot M, Heinrichs SC, Menzaghi F, Koob GF and Britton KT (1993) Anxiolytic-like action of neuropeptide Y: Mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology 8:357-363.
13. Hua G-Y, Boublik JH, Spicer MA, Rivier JE, Brown MR and Yaksh TL (1991) The antinociceptive effects of spinally administered neuropeptide Y in the rat: systematic studies on structure-activity relationship. J Pharmacol Exp Ther 258:243-248.
14. Josselyn SA and Beninger RJ (1993) Neuropeptide Y: Intraaccumbens injections produce a place preference that is blocked by cis-flupenthixol. Pharmacol Biochem Behav 46:543-552.
15. Kerr FWL and Pozuelo J (1971) Suppression of physical dependence and induction of hypersensitivity to morphine by stereotaxic hypothalamic lesions in addicted rats. Mayo Clin Proc 46:653-665.
16. Klatt DS, Guinan MJ, Culhane ES, Carstens E and Watkins LR (1988) The dorsal raphe nucleus: a re-evaluation of its proposed role in opiate analgesia systems. Brain Res 447:246-252.
17. Koob GF, Maldonado R and Stinus L ( 1992) Neural substrates of opiate withdrawal. TINS 15:186-191.
18. Lee PHK., McNutt RW and Chang K-J (1993) A nonpeptidic delta opioid receptor agonist, BW373U86, attenuates the development and expression of morphine abstinence precipitated by naloxone in rat. J Pharmacol Exp Ther 267:883-887.
19. Levine AS and Morley JE (1984) Neuropeptide Y: A potent inducer of consummatory behavior in rats. Peptides 5:1025-1029.
20. Levine AS, Morley JE, Gosnell BA, Billington CJ and Bartness TJ (1985) Opioids and consummatory behavior. Brain Res Bull 14:663-672.
21. MacLean PD (1957) Chemical and electrical stimulation of hippocampus in unrestrained animals. AMA Arch Neurol Psychiat 78:128-142.
22. Maldonado R, Stinus L, Gold LH and Koob GF (1992) Role of different brains structures in the expression of the physical morphine withdrawal syndrome. J Pharmacol Exp Ther 261:669-677.
23. Martin WR, Wikler A, Eades CG and Pescor FT (1963) Tolerance to and physical dependence on morphine in rats. Psychopharmacologia 4:247-260.
24. Mitchell CL, Grimes LM and Hong JS (1990) Granule cells in the ventral dentate gyrus are essential for kainic acid-induced wet dog shakes but not those induced by precipitated abstinence in morphine-dependent rats. Brain Res 511:338-340.
25. Morley JE and Levine AS (1980) Stress-induced eating is mediated through endogenous opiates. Science 209:1259-1261.
26. Pages N, Orosco M, Fournier G, Rouch C, Hafi A, Gourch A, Comoy E and Bohuon C (1991) The effects of chronic administration of morphine on the levels of brain and adrenal catecholamines and neuropeptide Y in rats. Gen Pharmacol 22:943-947.
27. Pages N, Orosco M, Rouch C, Fournier G, Comoy E and Bohuon C (1992) Brain and adrenal monoamines and neuropeptide Y in codeine tolerant rats. Gen Pharmacol 23:59-163.
28. Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press. New York.
29. Pich ME, Zoli M, Zini I, Ferraguti F, Solfrini V, Tiengo M, Fuxe K and Agnati LF (1990) Effects of central administration of neuropeptide Y on vigilance and pain threshold in spontaneously hypertensive rats. Adv Pain Res Ther 13:55-63.
30. Sperk G (1994) Kainic acid seizures in the rat. Prog Neurobiol 42:1-32.
31. Stanley BG and Leibowitz SF (1985) Neuropeptide Y injected in the paraventricular hypothalamus: A powerful stimulant of feeding behaviour. Proc Natl Acad Sci USA 82:3940-3943.
32. Takeshige C, Oka K, Mizuno T, Hisamitsu T, Luo C-P, Kobori M, Mera H and Fang T-Q (1993) The acupuncture point and its connecting central pathway for producing acupuncture analgesia. Brain Res Bull 30:53-67.
33. Tatemoto K, Carlquist M and Mutt V (1982) Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296:659-660.
34. Tremblay EC and Charton G (1981) Anatomical correlates of morphine-withdrawal syndrome: differential participation of structures located within the limbic system and striatum. Neurosci Lett 23:137-142.
35. Wahlestedt C, Karoum F, Jaskino G, Wyatt RJ, Larhammer D, Ekman R and Reis DJ (1991) Cocaine-induced reduction of brain neuropeptide Y synthesis dependent on medial prefrontal cortex. Proc Natl Acad Sci USA 88:2078-2082.
36. Wahlestedt C and Reis DJ (1993) Neuropeptide Y-related peptides and their receptors - are the receptors potential therapeutic drug targets? Annu Rev Pharmacol Toxicol 32:309-352.
37. Wahlestedt C, Pich EM, Koob GF, Yee F and Heilig M (1993) Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science 259: 528-531.
38. Wei E, Loh HH and Way EL (1972) Neuroanatomical correlates of morphine dependence. Science 177:616-617.
39. Weinberg DH, Sirinathsinghji DJP, Tan CP, Shiao L-L, Morin N, Rigby MR, Heavens RH, Rapoport DR, Bayne ML, Cascieri MA, Strader CD, Linemeyer DL and MacNeil DJ (1996) Cloning and expression of a novel neuropeptide Y receptor. J Biol Chem 271:16435-16438.
40. Woldbye DPD, Madsen TM, Larsen PJ, Mikkelsen JD and Bolwig TG (1996) Neuropeptide Y inhibits hippocampal seizures and wet dog shakes. Brain Res 737:162-168.
41. Woldbye DPD, Larsen PJ, Mikkelsen JD, Hemp K, Madsen TM and Bolwig TG (1997) Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors. Nature Med 3:761-764.
42. Yaksh TL (1979) Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal gray. Brain Res 160:180-185.